Search results
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
The Parsons Sun· 7 days ago- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing ...
Can You Fly with Ulcerative Colitis? Tips and More
Healthline· 3 days agoTraveling with ulcerative colitis can create unique challenges, but it’s still possible with appropriate planning and preparation. Ulcerative< ...
ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance...
WTRF Wheeling· 3 days agoThe data was shared during 18 oral and poster presentations at the Digestive Disease...
6 Signs of an Autoimmune Disease That Can Be Easy to Miss
Self via Yahoo News· 7 days agoAll of this spurs inflammation that might lead to well-known GI symptoms, like bloating, diarrhea,...
How biologics can help with symptoms of Crohn's
Medical News Today· 7 days agoBiologic therapies for Crohn’s disease (CD) do more than reduce the common symptoms of diarrhea, abdominal cramping, and pain. CD and ulcerative
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 4 days ago...PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients with moderately to severely active ulcerative colitisa (UC) receiving subcutaneous (SC) TREMFYA® (guselkumab) 200 mg every four...
Pediatric Crohn's disease: Symptoms and treatment
Medical News Today· 2 days agoPediatric Crohn’s disease is Crohn’s disease that affects those younger than 18 years old. Crohn’s disease is a type of inflammatory bowel disease (IBD)...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 14 hours agoAbbVie Completes Acquisition of Landos Biopharma PR Newswire NORTH CHICAGO, Ill., May 23, 2024 - Adds first-in-class investigational asset, NX-13, to AbbVie's pipeline with the potential to ...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 3 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey, Senior Vice President...
Anti-inflammatory diet guide: Foods, benefits and meal plan
The Telegraph via Yahoo News· 4 days agoIgnore chronic inflammation at your peril. Recognised as a contributor to many deaths globally, half...